Skip to main content
DexcomNews

Dexcom reaffirms CGM benefits for all people with diabetes and continues momentum toward earlier stage intervention and preventative care at ADA 2026.

What happened

Dexcom, Inc. acquired NutriSense on Jun 5th '26.

Source

Article excerpt

Highlighted: the sentence this signal was extracted from

Dexcom reaffirms CGM benefits for all people with diabetes and continues momentum toward earlier stage intervention and preventative care at ADA 2026. * Highly anticipated presentation of results from the CONNECT randomized control trial will be presented during the ADA Scientific Sessions conference on Saturday, June 6 at 1:45 p.m. CDT. * Early access launch of a completely reimagined Stelo app will define a new era of glucose tracking for all people not on insulin seeking better health. * Acquisition of Nutrisense will strengthen Dexcom's ability to provide personalized nutrition education and coaching to improve diabetes management and help further establish CGM as an effective tool for preventative care. SAN DIEGO-(BUSINESS WIRE)-DexCom, Inc. (NASDAQ:DXCM) will present new clinical findings, product advancements and strategic business initiatives reinforcing its commitment to improving care for people with all types of diabetes and ushering in a new era of early stage CGM intervention and preventative care at the American Diabetes Association's Scientific Sessions in New Orleans, June 5-8, 2026. "Dexcom has built a legacy of innovation within the diabetes space and as we look to the future, expanding access and developing new CGM solutions to better support early-stage intervention and preventative care are top priorities," said Jake Leach, president and CEO at Dexcom...

Keep reading with a free account

The rest of this article, and every signal for Dexcom, is in your free account.

Extracted by Autobound

From the Signal API record
Event
News

What this signalsIntegration work after a deal often opens needs for new systems and services.

Takes effect
Jun 5, 2026
Location
New Orleans, Louisiana, United States

Companies

  • NutriSenseTargetnutrisense.io

The full record

From the Signal API record

Details

Ticker
NASDAQ:DXCM

Extraction

Confidence
77%
Detected
Jun 4, 2026
signal_type
news
signal_subtype
acquires

Use this data

Get every news signal for Dexcom and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Dexcom this week?”

  2. Send it to your own tools

    The Signal API returns news signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full news record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/eea3dd39-2317-4249-8bfc-534b6b735a8e returns this record as JSON. POST /v1/companies/enrich returns every signal for dexcom.com.

{
  "signal_id": "eea3dd39-2317-4249-8bfc-534b6b735a8e",
  "signal_type": "news",
  "signal_subtype": "acquires",
  "detected_at": "2026-06-04T16:00:00+00:00",
  "company": {
    "name": "Dexcom",
    "domain": "dexcom.com"
  },
  "data": {
    "url": "https://healthtechhotspot.com/dexcom-reaffirms-cgm-benefits-for-all-people-with-diabetes-and-continues-momentum-toward-earlier-stage-intervention-and-preventative-care-at-ada-2026",
    "title": "Dexcom reaffirms CGM benefits for all people with diabetes and continues momentum toward earlier stage intervention and preventative care at ADA 2026.",
    "ticker": "NASDAQ:DXCM",
    "excerpt": "Dexcom reaffirms CGM benefits for all people with diabetes and continues momentum toward earlier stage intervention and preventative care at ADA 2026.\n\n* Highly anticipated presentation of results from the CONNECT randomized control trial will be presented during the ADA Scientific Sessions conference on Saturday, June 6 at 1:45 p.m. CDT.\n* Early access launch of a completely reimagined Stelo app will define a new era of glucose tracking for all people not on insulin seeking better health.\n* Acquisition of Nutrisense will strengthen Dexcom's ability to provide personalized nutrition education and coaching to improve diabetes management and help further establish CGM as an effective tool for preventative care.\n\nSAN DIEGO-(BUSINESS WIRE)-DexCom, Inc. (NASDAQ:DXCM) will present new clinical findings, product advancements and strategic business initiatives reinforcing its commitment to improving care for people with all types of diabetes and ushering in a new era of early stage CGM intervention and preventative care at the American Diabetes Association's Scientific Sessions in New Orleans, June 5-8, 2026.\n\n\"Dexcom has built a legacy of innovation within the diabetes space and as we look to the future, expanding access and developing new CGM solutions to better support early-stage intervention and preventative care are top priorities,\" said Jake Leach, president and CEO at Dexcom...",
    "summary": "Dexcom, Inc. acquired NutriSense on Jun 5th '26.",
    "location": "New Orleans, Louisiana, United States, Northern America, Americas",
    "planning": false,
    "image_url": "https://mms.businesswire.com/media/20260604501578/en/2823923/22/Dexcom_ADA.jpg",
    "confidence": 0.7735,
    "published_at": "2026-06-04T16:00:00Z",
    "location_data": [
      {
        "city": "New Orleans",
        "state": "Louisiana",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "effective_date": "2026-06-05",
    "article_sentence": "* Acquisition of Nutrisense will strengthen Dexcom's ability to provide personalized nutrition education and coaching to improve diabetes management and help further establish CGM as an effective tool for preventative care.",
    "related_company_name": "NutriSense",
    "related_company_domain": "nutrisense.io"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.